Literature DB >> 35982351

Ultrasound evaluation of endothelial dysfunction in immunoglobulin-resistant children with acute Kawasaki disease.

Yizhou Wen1, Yanfeng Yang2, Yang Wen3, Jimei Xi3, Tingting Chen4, Yaheng Lu4, Li Wang5, Yiling Liu4, Feifei Si4.   

Abstract

INTRODUCTION: Given the evidence that brachial artery flow-mediated dilation (FMD) is declined in children later after the onset of Kawasaki disease (KD), we hypothesized that indicators that detect the situation of the endothelium are useful parameters that can accurately reflect subclinical dysfunction in resistant patients and assist in differentiating patients with KD at a higher risk of IVIG resistance, which may be valuable in better understanding how to protect patients from endothelial and thrombotic complications.
METHODS: Fifty IVIG-resistant KD children, 120 IVIG-responsive KD children, 35 febrile children with acute upper respiratory infection, and 50 healthy controls were recruited, and indicators reflecting endothelial inflammation, including flow-mediated dilation (FMD), were measured. Receiver operating characteristic (ROC) curve analysis was utilized to determine the threshold values of these indicators of IVIG resistance. Multiple logistic regression analysis was performed to determine whether FMD was an independent predictor of IVIG-resistant patients.
RESULTS: In comparison with the lab data, PCT, Na + , and FMD exhibited AUCs of 0.727, 0.653, and 0.698 (P < 0.05), respectively, in predicting IVIG resistance in KD through ROC analysis. PCT > 1.69 ng/ml, Na +  < 133.2 mmol/l, and FMD < 5.79% were independent predictors of IVIG resistance in KD (OR 4.257, 3.516, 3.563, 95% CI 1.549 ~ 11.700, 1.277 ~ 9.680, 1.299 ~ 9.772, P < 0.05).
CONCLUSION: More severe endothelial dysfunction, especially lower FMD, was present in IVIG-resistant patients than in IVIG-responsive patients. It is a helpful diagnostic tool that provides supportive criteria to detect KD patients at a higher risk of IVIG resistance when FMD < 5.79% in children. Key Points • IVIG-resistant KD patients have more severe endothelial dysfunction than IVIG-sensitive patients. • FMD < 5.79% may indicate an increased risk of IVIG resistance in children with Kawasaki disease.
© 2022. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).

Entities:  

Keywords:  Cardiology; Endothelium dysfunction; Intravenous immune globulin resistance; Kawasaki disease; Ultrasound

Year:  2022        PMID: 35982351     DOI: 10.1007/s10067-022-06341-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  39 in total

Review 1.  From endothelial dysfunction to atherosclerosis.

Authors:  S Sitia; L Tomasoni; F Atzeni; G Ambrosio; C Cordiano; A Catapano; S Tramontana; F Perticone; P Naccarato; P Camici; E Picano; L Cortigiani; M Bevilacqua; L Milazzo; D Cusi; C Barlassina; P Sarzi-Puttini; M Turiel
Journal:  Autoimmun Rev       Date:  2010-07-30       Impact factor: 9.754

Review 2.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.

Authors:  Brian W McCrindle; Anne H Rowley; Jane W Newburger; Jane C Burns; Anne F Bolger; Michael Gewitz; Annette L Baker; Mary Anne Jackson; Masato Takahashi; Pinak B Shah; Tohru Kobayashi; Mei-Hwan Wu; Tsutomu T Saji; Elfriede Pahl
Journal:  Circulation       Date:  2017-03-29       Impact factor: 29.690

3.  Non-invasive assessment of endothelial function: which technique?

Authors:  Ann E Donald; Marietta Charakida; Tim J Cole; Peter Friberg; Phil J Chowienczyk; Sandrine C Millasseau; John E Deanfield; Julian P Halcox
Journal:  J Am Coll Cardiol       Date:  2006-10-17       Impact factor: 24.094

4.  Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS.

Authors:  Francesco Salton; Paola Confalonieri; Giuseppina Campisciano; Rossella Cifaldi; Clara Rizzardi; Daniele Generali; Riccardo Pozzan; Stefano Tavano; Chiara Bozzi; Giulia Lapadula; Gianfranco Umberto Meduri; Marco Confalonieri; Manola Comar; Selene Lerda; Barbara Ruaro
Journal:  J Clin Med       Date:  2022-05-24       Impact factor: 4.964

5.  Do cytokines correlate with refractory Kawasaki disease in children?

Authors:  Ying Wang; Su Yun Qian; Yue Yuan; Qin Wang; Lu Gao; Xi Chen; Xia Yu; Zhen Zhen
Journal:  Clin Chim Acta       Date:  2020-03-07       Impact factor: 3.786

Review 6.  Refractory Kawasaki disease: diagnostic and management challenges.

Authors:  Sophie Duignan; Sarah L Doyle; Colin J McMahon
Journal:  Pediatric Health Med Ther       Date:  2019-10-30

7.  Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.

Authors:  Toshiyuki Kitoh; Tsuyoshi Ohara; Taichiro Muto; Akihisa Okumura; Reizo Baba; Yusuke Koizumi; Yuka Yamagishi; Hiroshige Mikamo; Kenji Daigo; Takao Hamakubo
Journal:  Front Immunol       Date:  2021-04-12       Impact factor: 7.561

Review 8.  Kawasaki Disease and COVID-19.

Authors:  Athanasios Gkoutzourelas; Dimitrios P Bogdanos; Lazaros I Sakkas
Journal:  Mediterr J Rheumatol       Date:  2020-09-21

Review 9.  Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease.

Authors:  Rui Long Zhang; Hang Hong Lo; Cheng Lei; Nikki Ip; Juan Chen; Betty Yuen-Kwan Law
Journal:  Curr Opin Pharmacol       Date:  2020-09-18       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.